Enjoy complimentary customisation on priority with our Enterprise License!
The projected expansion of the global microfluidics market in the healthcare sector is anticipated to reach a value of USD 43.27 billion by 2027, with a notable compound annual growth rate (CAGR) of 19.81% during the period spanning from 2022 to 2027. In terms of market share, the United States emerged as the leader in 2017, generating an annual revenue of USD 4.80 billion. The comprehensive market growth analysis report offers extensive research on various applications, such as in-vitro diagnostics, pharmaceutical research, and drug delivery services. Furthermore, the market is segmented based on material, including polymer-based, glass-based, and silicon-based options. Geographically, the report provides segmentation for North America, Europe, APAC, South America, and Middle East and Africa regions. The market analysis and expansion study encompass the measurement of the market, past data (2017-2021), and future estimations expressed in terms of value (in USD billion) for all the indicated segments.
For further insights into this report, please proceed to download a sample of the report.
The in-vitro diagnostics sector achieved a valuation of USD 8.46 billion in 2017 and experienced continuous growth until 2021. The market share of the in-vitro diagnostics segment is expected to exhibit substantial expansion throughout the projected timeframe. In-vitro diagnostics holds a prominent position within the realm of microfluidic healthcare applications. The potential of microfluidics in the field of diagnostics is substantial. Microfluidic diagnostic kits capitalize on compact integrated systems to achieve quick turnaround times, delivering instant outcomes and minimizing expenses. Cepheid's automated microfluidic polymerase chain reaction (PCR) is an alternate system employed for the swift screening and diagnosis of methicillin-resistant Staphylococcus aureus (MRSA) infections in hospital settings. Its implementation has facilitated regular health monitoring for both medical practitioners and patients, resulting in significant market investment due to these notable benefits.
To obtain additional information regarding other sections, please download a sample report.
Large companies are interested in In-vitro diagnostics technology and are investing in or acquiring smaller companies in this space. Such factors are anticipated to drive the growth of the in-vitro diagnostics segment of the microfluidics market for healthcare applications during the forecast period.
The market in North America occupies a significant position- It is projected that North America will account for 44% of the global market growth in the foreseeable future. The presence of numerous medical device manufacturers in the region contributes to the expansion of the microfluidics market for healthcare applications in North America. Key players in this region include Baxter, Beckman Coulter, BD, Boston Scientific, GENERAL ELECTRIC, Johnson and Johnson Services, Medtronic, St. Jude and Stryker are expanding their financial commitment toward the development and distribution of a wide variety of medical devices that Technavio anticipates will incorporate a significant array of microfluidic devices. This is anticipated to drive the expansion of the targeted market in North America.
To comprehend geographical patterns, it is recommended to download a sample of the report.
The demand for medical devices in North America is further increase by the growing need for such devices in the region. The United States, being the largest market and a significant exporter of medical devices, plays a crucial role in driving the market in this region. In 2020, the market value of medical devices in the United States was around USD 176 billion, making it one of the most profitable markets globally in terms of sales. Forecasts suggest that the United States will maintain its position as the global leader in the medical devices market in the coming years. The rising elderly population in the United States, coupled with heightened healthcare expenditures by the US government towards research and development in the medical field, are the primary drivers of the demand for medical devices in both domestic and international markets.
The market growth of microfluidic devices is significantly influenced by their compact nature. These devices, which are small in size and require smaller amounts of reagents, result in cost savings and decreased medical waste. Their diminutive dimensions, large surface area relative to volume, and minimal thermal mass facilitate accurate temperature regulation, quick heat transfer, and swift adjustment to temperature fluctuations. This guarantees rapid liquid diffusion, enhancing the precision and speed of reactions, thereby improving the performance of assays, minimizing measurement time, and amplifying sensitivity. For instance, microfluidic devices mitigate dispersion in electrophoretic separations by efficiently dissipating Joule heat, resulting in sharper peaks and heightened sensitivity. Furthermore, healthcare microfluidics market growth is propelled by the utilization of microfluidic devices to optimize fluid temperature through the passage of fluids across chip regions with varying temperatures.
The compact size of microfluidic devices is notably driving the microfluidic market for healthcare application growth. Microfluidic devices are compact and use fewer reagents, resulting in lower costs and less medical waste. The large surface area-to-volume ratio and low thermal mass of these devices facilitate precise temperature control, rapid heat transfer, and rapid adaptation to temperature changes. Due to the small size of microfluidic devices, the rapid diffusion of liquids improves the accuracy and speed of reactions. This improves the performance of microfluidic assays, shortens measurement times, and increases assay sensitivity.
For example, microfluidic devices can help reduce dispersion broadening in electrophoretic separations by rapidly dissipating Joule heat. Shortening the measurement time reduces peak broadening and thus improves sensitivity for some separations. Also, microfluidic devices are used to recycle fluid temperature by forcing the fluid to flow through different chip regions at different temperatures. Such factors are anticipated to drive the growth of the microfluidics market for healthcare applications during the forecast period.
The use of paper-based microfluidic devices is a key trend influencing the microfluidic market for healthcare application growth. Paper-based microfluidic devices use hydrophobic channel walls printed on paper. These hydrophobic walls ensure controlled velocity and direction of liquid flow. Using paper in the manufacture of such devices greatly reduces the cost of these devices and simplifies their disposal. In 2020, paper-based technology was limited to simple design devices. However, the fabrication of microfluidic devices from paper technology is expected to have a significant impact on the microfluidic market during the forecast period. One of the first steps in the treatment of any disease is to perform a diagnostic analysis of the patient. There are several disease-detection devices and instruments on the market, but they are very expensive.
Additionally, these devices and equipment require trained professionals to operate, further increasing costs. To overcome these problems, researchers are focusing on developing paper-based microfluidic devices. In this process, the substrate for generating microfluids consists of paper. Paper microfluidic devices are inexpensive and environmental friendly. Therefore, these devices are in great demand in both developed and developing countries. Another key feature making paper microfluidics a major trend in the global microfluidics market for healthcare applications is the ability to instantly perform multiple medical tests using chips. This can be done when there is an urgent need or in remote areas where basic facilities such as electricity are not available to power medical equipment. All these factors make them highly attractive and are likely to drive the growth of the market.
The changes in the properties of fluids at the microscopic level are challenging the microfluidic market for healthcare application growth. Microfluidics tend to change their physical properties at the microscopic level. A fluid behaves very differently at the micro-scale compared to using the same fluid at the macro scale. At a smaller level, features such as surface tension, fluid resistance, and energy dissipation come to the fore. The Reynolds number compares the effect of the momentum of a liquid to the effect of its viscosity. At the micron level, the Reynolds number becomes very low, and the flow becomes laminar instead of turbulent. In laminar flow, liquids mix only by diffusion processes. Diffusion is a rather slow mechanism that makes reactions in microfluidic devices more difficult to achieve. As a result, measurement errors can occur that can lead to erroneous readings in multiple medical tests.
Further, another important property to consider in drug testing is slip resistance. At the micro level, no slip occurs between liquids and solids. Liquid molecules adhere to a solid surface and the liquid moves against it. This indicates that the bottom remains stationary while the top of the liquid moves at the same speed. This leads to the formation of shear stress, an important factor to consider in drug testing. Shear stress should be considered when designing microfluidic chips, as increased shear stress indicates a lack of flow, thereby limiting the study of cell interactions. Therefore, shear stress must be modeled or calculated when designing microfluidic devices such as chips. Such factors are expected to hinder the growth of the microfluidics market for healthcare applications during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and trends report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market Forecasting report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2023 to 2027, as well as historical data from 2018 to 2023 for the following segments
You may also interested in below market reports:
The market in North America occupies a significant position-It is projected that North America will account for 44% of the global market growth in the foreseeable future. The presence of numerous medical device manufacturers in the region contributes to the expansion of the microfluidics market for healthcare applications in North America. Key players in this region include Baxter, Beckman Coulter, BD, Boston Scientific, GENERAL ELECTRIC, Johnson and Johnson Services, Medtronic, and St. Jude and Stryker are expanding their financial commitment toward the development and distribution of a wide variety of medical devices that Technavio anticipates will incorporate a significant array of microfluidic devices. This is anticipated to drive the expansion of the targeted market in North America.
Market Scope |
|
Report Coverage |
Details |
Page number |
166 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 20.16% |
Market growth 2023-2027 |
USD 59.76 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
19.47 |
Regional analysis |
North America, Europe, APAC, South America, and Middle East and Africa |
Performing market contribution |
North America at 45% |
Key countries |
US, China, Japan, Germany, and UK |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
908 Devices Inc., Agilent Technologies Inc., bioMerieux SA, Bio Rad Laboratories Inc., Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Fluigent SA, General Electric Co., Hamilton Bonaduz AG, Illumina Inc., Microfluidic Chipshop GmbH, MICRUX FLUIDIC S.L., Perkin Elmer Inc., SMC Corp., Teledyne Technologies Inc., Thermo Fisher Scientific Inc., uFluidix Inc., and QIAGEN NV |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Material
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.